|
|
 |
 |
|  |  |
 |  |  |  |  |
organism-gene
 |


|
 PR:P02749 |
   beta-2-glycoprotein 1 (human)
 |
   hAPOH
 |
  "A beta-2-glycoprotein 1 that is encoded in the genome of human." [PRO:DNx, UniProtKB:P02749]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-sequence
 |


|
 PR:P02749-1 |
   beta-2-glycoprotein 1 isoform 1 (human)
 |
   hAPOH/iso:1
 |
  "A beta-2-glycoprotein 1 isoform 1 that is encoded in the genome of human." [PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000046365 |
   beta-2-glycoprotein 1, signal peptide removed form (human)
 |
   hAPOH/SigPep-
 |
  "A beta-2-glycoprotein 1 (human) that has had the signal peptide removed. UniProtKB:P02749, 20-345." [PRO:DNx, Reactome:R-HSA-8848901, Reactome:R-HSA-8848905]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052748 |
   beta-2-glycoprotein 1 N-glycosylated 1 (human)
 |
   hAPOH/NGlyco:1
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P02749-1, Asn-162, MOD:00160~GNO:G00912UN." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052749 |
   beta-2-glycoprotein 1 N-glycosylated 2 (human)
 |
   hAPOH/NGlyco:2
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P02749-1, Asn-162, MOD:00160~GNO:G06247RL." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052750 |
   beta-2-glycoprotein 1 N-glycosylated 3 (human)
 |
   hAPOH/NGlyco:3
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P02749-1, Asn-162, MOD:00160~GNO:G08293MJ." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052751 |
   beta-2-glycoprotein 1 N-glycosylated 4 (human)
 |
   hAPOH/NGlyco:4
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan structure is represented by GlyTouCan:G22140GZ. Example: UniProtKB:P02749-1, Asn-162, MOD:00160~GNO:G22140GZ." [GlyGen:P02749-1, PMID:19838169, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052752 |
   beta-2-glycoprotein 1 N-glycosylated 5 (human)
 |
   hAPOH/NGlyco:5
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P02749-1, Asn-162, MOD:00160~GNO:G27947YN." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052753 |
   beta-2-glycoprotein 1 N-glycosylated 6 (human)
 |
   hAPOH/NGlyco:6
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan structure is represented by GlyTouCan:G36131WL. Example: UniProtKB:P02749-1, Asn-162, MOD:00160~GNO:G36131WL." [GlyGen:P02749-1, PMID:19838169, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052754 |
   beta-2-glycoprotein 1 N-glycosylated 7 (human)
 |
   hAPOH/NGlyco:7
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P02749-1, Asn-162, MOD:00160~GNO:G59626AS." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052755 |
   beta-2-glycoprotein 1 N-glycosylated 8 (human)
 |
   hAPOH/NGlyco:8
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G85144OK. Example: UniProtKB:P02749-1, Asn-162, MOD:00160~GNO:G85144OK." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052756 |
   beta-2-glycoprotein 1 N-glycosylated 9 (human)
 |
   hAPOH/NGlyco:9
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P02749-1, Asn-162, MOD:00160~GNO:G88374WZ." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052757 |
   beta-2-glycoprotein 1 N-glycosylated 10 (human)
 |
   hAPOH/NGlyco:10
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-162 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P02749-1, Asn-162, MOD:00160~GNO:G94917XT." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052758 |
   beta-2-glycoprotein 1 N-glycosylated 11 (human)
 |
   hAPOH/NGlyco:11
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G00912UN. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G00912UN." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052759 |
   beta-2-glycoprotein 1 N-glycosylated 12 (human)
 |
   hAPOH/NGlyco:12
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G57776ZU. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G57776ZU." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052760 |
   beta-2-glycoprotein 1 N-glycosylated 13 (human)
 |
   hAPOH/NGlyco:13
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G06247RL. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G06247RL." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052761 |
   beta-2-glycoprotein 1 N-glycosylated 14 (human)
 |
   hAPOH/NGlyco:14
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G08293MJ. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G08293MJ." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052762 |
   beta-2-glycoprotein 1 N-glycosylated 15 (human)
 |
   hAPOH/NGlyco:15
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G10486CT. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G10486CT." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052763 |
   beta-2-glycoprotein 1 N-glycosylated 16 (human)
 |
   hAPOH/NGlyco:16
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G27947YN. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G27947YN." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052764 |
   beta-2-glycoprotein 1 N-glycosylated 17 (human)
 |
   hAPOH/NGlyco:17
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G40926MX. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G40926MX." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052765 |
   beta-2-glycoprotein 1 N-glycosylated 18 (human)
 |
   hAPOH/NGlyco:18
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan structure is represented by GlyTouCan:G42358LZ. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G42358LZ." [GlyGen:P02749-1, PMID:24279413, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052767 |
   beta-2-glycoprotein 1 N-glycosylated 20 (human)
 |
   hAPOH/NGlyco:20
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G59626AS. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G59626AS." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052768 |
   beta-2-glycoprotein 1 N-glycosylated 21 (human)
 |
   hAPOH/NGlyco:21
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G88374WZ. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G88374WZ." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
 |
 |
|  |  |  |  |
 |  |  |
organism-modification
 |


|
 PR:000052769 |
   beta-2-glycoprotein 1 N-glycosylated 22 (human)
 |
   hAPOH/NGlyco:22
 |
  "A beta-2-glycoprotein 1 (human) that has been N-glycosylated at the residue equivalent to Asn-253 of the amino acid sequence represented by UniProtKB:P02749-1, in which the glycan composition is represented by GlyTouCan:G94917XT. Example: UniProtKB:P02749-1, Asn-253, MOD:00160~GNO:G94917XT." [GlyGen:P02749-1, PMID:29671580, PRO:DNx]
 |

| 
|
|
|
|